| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 49,039 | 54,832 | ||
| Prepaid expenses and other current assets | 1,771 | 3,492 | ||
| Total current assets | 50,810 | 58,324 | ||
| Equity investment | 0 | 0 | ||
| Total property and equipment | 2,823 | - | ||
| Less accumulated depreciation | 1,754 | - | ||
| Property and equipment, net | 1,069 | 1,160 | ||
| Right-of-use asset, operating leases | 5,258 | 5,416 | ||
| Restricted cash and restricted cash equivalents | 647 | 647 | ||
| Other noncurrent assets | 0 | 570 | ||
| Total assets | 57,784 | 66,117 | ||
| Accounts payable | 973 | 910 | ||
| Accrued expenses and other current liabilities | 3,905 | 4,396 | ||
| Cvr liability | 0 | 0 | ||
| Venture debt, current portion | 6,232 | 6,228 | ||
| Total current liabilities | 11,110 | 11,534 | ||
| Lease liability, net of current portion | 5,121 | 5,296 | ||
| Venture debt, net of current portion | 5,001 | 6,522 | ||
| Other noncurrent liabilities | 55,000 | 55,000 | ||
| Total liabilities | 76,232 | 78,352 | ||
| Common stock, 0.0001 par value 400,000,000 shares authorized, 12,304,352 and 12,197,615 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 2 | 2 | ||
| Additional paid-in capital | 244,273 | 243,097 | ||
| Accumulated other comprehensive gain (loss) | 0 | 0 | ||
| Accumulated deficit | -262,723 | -255,334 | ||
| Total stockholders' equity (deficit) | -18,448 | -12,235 | ||
| Total liabilities and stockholders' equity (deficit) | 57,784 | 66,117 | ||
Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB)